Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

30.25
+0.83002.82%
Pre-market: 30.08-0.1750-0.58%04:00 EDT
Volume:3.29M
Turnover:98.04M
Market Cap:2.17B
PE:-5.13
High:30.61
Open:29.09
Low:28.46
Close:29.42
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.73
T/O Rate:6.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.32
PE(LYR):-6.49

Loading ...

Feb 14, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 30, 2023

Major Issues Report

8-K - Current report
Jan 27, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 09, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 26, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]